http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
I. Fundamental considerations -- Overview of ocular drug delivery -- Membrane transport processes in the eye -- General considerations in ocular drug delivery -- II. Transport models in ocular drug delivery -- Ocular drug transfer following systemic drug administration -- Ocular pharmacokinetics and pharmacodynamics -- Mathematical modeling of drug distribution in the vitreous humor -- Anterior segment microdialysis -- Posterior segment microdialysis -- III. Drug delivery systems -- A : Coventional systems -- Ocular penetration enhancers -- Corneal collagen shields for ocular drug delivery -- The noncorneal route in ocular drug delivery -- Ocular iontophoresis -- Mucoadhesive polymers in ophthalmic drug delivery -- Microparticles and nanoparticles in ocular drug delivery -- Dendrimers : an innovative and enhanced ocular drug delivery system -- B : Delivery of macromolecular therapeutic agents -- Ocular delivery and therapeutics of proteins and peptides -- Retinal disease models for development of drug and gene therapies -- New experimental therapeutic approaches for degenerative diseases of the retina -- Gene, oligonucleotide, and ribozyme therapy in the eye -- IV. Regulatory aspects -- Regulatory considerations -- Patent considerations
Includes bibliographical references and index.
Drugs and the pharmaceutical sciences ; 130